Nateglinide Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 60 mg, 120 mg, 180 mg
Reference Brands: Starlix (USA)
Category: Diabetes
Nateglinide is available in Tablets and strengths such as 60 mg, 120 mg, 180 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Nateglinide is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Nateglinide can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Nateglinide is an oral antidiabetic medication used to manage blood glucose levels in patients with type 2 diabetes mellitus. It belongs to the meglitinide class of drugs and works by stimulating insulin release from the pancreas in response to meals, thereby helping control postprandial blood sugar levels.
The mechanism of action of nateglinide involves closing ATP-dependent potassium channels in the membrane of pancreatic β cells. This closure leads to depolarization of the β cells, which triggers the opening of voltage-gated calcium channels. The resulting influx of calcium promotes the fusion of insulin-containing vesicles with the cell membrane, leading to the secretion of insulin into the bloodstream.
By enhancing insulin secretion, nateglinide helps lower blood glucose effectively after meals and supports overall glycemic control. It is typically taken shortly before meals and is used alongside diet and exercise for optimal diabetes management. Regular use as prescribed helps reduce the risk of long-term complications associated with uncontrolled type 2 diabetes.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Nateglinide is used to treat type 2 diabetes mellitus and control blood sugar levels, especially postprandial hyperglycemia.
Nateglinide is a chemically synthesized meglitinide-class oral antidiabetic drug.
The trade name of nateglinide is Starlix.
Starlix is manufactured and marketed by Novartis Pharmaceuticals, with generic versions produced by multiple companies.
The generic name of Nateglinide is nateglinide.
The brand name of Nateglinide is Starlix.
Nateglinide is manufactured in multiple countries including the United States, India, and EU nations, depending on the manufacturer and regulatory approvals.
Related Products
Pioglitazone Hydrochloride
Strength:
15 mg, 30 mg, 45 mg
Form: Tablets
Reference Brands: Actos (USA)
View DetailsMiglitol
Strength:
25 mg, 50 mg, 100 mg
Form: Tablets
Reference Brands: Glyset (USA), Diastabol (EU)
View DetailsSotagliflozin
Strength:
200 mg, 40mg
Form: Tablets
Reference Brands: Inpefa (USA), Zynquista (EU)
View DetailsGlyburide
Strength:
1.25 mg, 2.5 mg, 5 mg
Form: Tablets
Reference Brands: Diabeta (USA), Micronase (USA), Glynase PresTab (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers